Thursday, July 21, 2011 12:19 AM
|
CCSVI in Multiple Sclerosis
New American Academy of Neurology study. Bottom line: MS drugs cost too much, and we really don't know if they do anything to slow the progression of MS. Study: MS Drugs Help, But Come at High Costwww.aan.com A new study examining the cost-effectiveness of drugs to treat multiple sclerosis (MS) in the United States finds that the health gains from these drugs come at a very high cost compared to basic therapy to control the symptoms of MS and compared to treatments for other chronic diseases. The resear
|